NCT05124249 Imaging and Physiologic Evaluation of Coronary Artery Disease
| NCT ID | NCT05124249 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chonnam National University Hospital |
| Condition | Ischemic Heart Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2021-11-01 |
| Primary Completion | 2029-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2021-11-01 with a primary completion date of 2029-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To evaluate the long-term clinical outcomes and prognostic factors in patients with coronary artery disease (CAD) undergoing invasive coronary angiography (ICA), intravascular imaging, or invasive physiologic assessment.
Eligibility Criteria
Inclusion Criteria: * Subject must be at least 18 years of age * Subjects who suspected ischemic heart disease and underwent ICA. * Subjects who were performed intravascular imaging or invasive physiologic assessment Exclusion Criteria: * Subject with Age \<18 years * Pregnant women
Contact & Investigator
Young Joon LeeHong, MD, PhD
PRINCIPAL INVESTIGATOR
Chonnam National University Medical School; Chonnam National University Hospital
Frequently Asked Questions
Who can join the NCT05124249 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Ischemic Heart Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05124249 currently recruiting?
Yes, NCT05124249 is actively recruiting participants. Contact the research team at hyj200@hanmail.net for enrollment information.
Where is the NCT05124249 trial being conducted?
This trial is being conducted at Gwangju, South Korea.
Who is sponsoring the NCT05124249 clinical trial?
NCT05124249 is sponsored by Chonnam National University Hospital. The principal investigator is Young Joon LeeHong, MD, PhD at Chonnam National University Medical School; Chonnam National University Hospital. The trial plans to enroll 2,000 participants.